Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Nevoid basal-cell carcinoma syndrome
Other

Nevoid basal-cell carcinoma syndrome

Tracked across 1 events · 6 articles · First seen Jun 15, 2026 · Last active Jun 15, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 0
Regulatory
Medicus Pharma Seeks SkinJect Designation
Impact: Gorlin Syndrome is a rare genetic disorder that Skinject aims to treat. The designation is specifically for this patient population, highlighting the unmet medical need.
Jun 15, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Nevoid basal-cell carcinoma syndrome live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.